tickstock newsroom AI
Articles
Ikigai Ventures buys Dotlines Group for £55.7m
Ikigai Ventures Limited will issue 585.3m new shares at 9.5p to acquire Dotlines Group, relaunch as Dotlines Global and seek AIM admission on 11 May.
Insig AI demonstrates Central Bank MCP server
Insig AI plc has published a live demonstration study showing its Central Bank Model Context Protocol server analysed 4,235 documents from 55 central banks — tracking 31,321 mentions of 76 conflict-related keywords to deliver a publishable insight in hours.
Beowulf Mining welcomes Swedish plan to upgrade Inlandsbanan
Beowulf Mining said the Swedish Government’s decision to prioritise critical infrastructure investment is a direct positive for its Kallak iron ore project, which lies about 40km from a key rail corridor.
RTW Biotech Opportunities value boosted by GLP-1 firm Kailera's landed 'record' IPO
Kailera’s upsized $625m Nasdaq listing sent RTW Biotech Opportunities Ltd’s holding sharply higher, validating the fund’s newco creation strategy and boosting private-portfolio value.
Kropz hits record month at Elandsfontein and says Hinda water risk mitigated
Kropz Plc reported a record 40,792 tonnes of phosphate concentrate at Elandsfontein in March, lifting Q4 output 11% quarter-on-quarter, while management says water challenges at the Hinda project no longer pose a material risk.
The Premarket Brief: GSK wins China approval for Blenrep in myeloma, Renishaw, Mulberry, Plus500, Supreme, Nanoco, ATOME, Smarter Web Company, Angus Energy
A busy premarket burst of newsflow holds a string of positive trading updates and regulatory wins across pharma, industrials, and consumer names, with GSK's China breakthrough and Renishaw's upgraded guidance setting the tone for a constructive open. Several smaller companies are also beating expectations
Nanoco Group posts £7.7m H1 revenue after $5m LG licence
ATOME extends Villeta funding longstop
Angus Energy lifts Saltfleetby production after workovers
Active Energy energises Ghummud site ahead of schedule
Eurasia Mining advances West Kytlim sale and Monchetundra design
Ferrexpo sells transhipper Iron Destiny for US$7.7m
Great Southern Copper kicks off three‑hole RC test at Piedras Blancas
AstraZeneca reports tozorakimab cuts COPD exacerbations in Phase III MIRANDA
Reabold explores bitcoin mining at West Newton
CelLBxHealth partners with The Royal Marsden on 200‑patient CTC study
CelLBxHealth will co-run a prospective 200‑patient translational study with The Royal Marsden to use circulating tumour cell (CTC) DNA profiling to find actionable mutations in advanced NSCLC patients whose ctDNA tests are uninformative.
evoke in talks over 50p-a-share approach from Bally's Intralot
Renishaw upgrades FY2026 revenue and profit guidance
Renishaw now expects FY2026 revenue of £775m–£805m and adjusted profit before tax of £145m–£165m after a surge in orders from semiconductor, electronics manufacturing equipment and aerospace & defence customers.
The Smarter Web Company places 4.29m shares to raise £1.54m
The Smarter Web Company PLC has placed new shares under its December subscription agreement, raising £1.53 million.
GSK wins China approval for Blenrep in 2L+ multiple myeloma
GSK has secured NMPA approval in China for Blenrep (belantamab mafodotin) plus bortezomib and dexamethasone for adults after at least one prior therapy, after DREAMM‑7 showed a 42% reduction in risk of death and nearly tripled median PFS versus a daratumumab-based triplet.